Amarin Corporation plc
corporate_fare Company Profile
Amarin Corporation plc (NASDAQ:AMRN) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 20 items for AMRN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-28, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for AMRN spans 10-Q, 8-K, SCHEDULE 13D/A, DEF 14A.
Recent high-impact activity:
- Amarin 10-Q Details First Quarterly Profit in Over Two Years and $323.4M Cash Pile
- Amarin Posts First Profitable Quarter in Over Two Years; Cash Rises to $323.4M
- Amarin Posts First Profit in Over Two Years as Expenses Fall 44%
- Sarissa Capital Sells 25.7M Amarin Shares, Cutting Stake to 6.09%
- Amarin Q2 Revenue Drops 42% to $42.2M as Licensing Income Evaporates; Cash Runway Remains Strong at $314.6M
Financial Snapshot
Short Interest & Short Volume
7.58 days to coverFINRA reported short interest of 537,876 shares in AMRN as of the October 30, 2026 settlement, a 1.0% increase from the prior period — about 7.6 days to cover at its recent average daily volume. On November 20, 2026, 44.5% of AMRN volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.